Global Polymer Coronary Stents Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Polymer Coronary Stents market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Polymer Coronary Stents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Polymer Coronary Stents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Polymer Coronary Stents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Polymer Coronary Stents include Wego Healthcare, Shandong Huaan Biotechnology, SINOMED, Translumina Therapeutics, SLTL Medical, Scitech Medical, Rontis, REVA Medical and Purple Microport, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polymer Coronary Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymer Coronary Stents.
The Polymer Coronary Stents market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polymer Coronary Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Polymer Coronary Stents Segment by Company

Wego Healthcare
Shandong Huaan Biotechnology
SINOMED
Translumina Therapeutics
SLTL Medical
Scitech Medical
Rontis
REVA Medical
Purple Microport
Meril Life
InSitu Technologies
HEALTHCARE TECHNOLOGY
Eucatech
Elixir Medical
CeloNova BioSciences
Biotronik
AMG International
Amaranth Medical Analytics
Alvimedica
Polymer Coronary Stents Segment by Type

Hybrid Stents
Biodegradable Polymer Stents
Resorbable Polymer Stents
Bare Metal Polymer Stents
Drug-Eluting Polymer Stents
Polymer Coronary Stents Segment by Application

Drug-Eluting
Post-Procedure Management
Percutaneous Coronary Intervention (PCI)
Polymer Coronary Stents Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymer Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymer Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymer Coronary Stents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymer Coronary Stents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Polymer Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Polymer Coronary Stents Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Polymer Coronary Stents Sales Estimates and Forecasts (2020-2031)
1.3 Polymer Coronary Stents Market by Type
1.3.1 Hybrid Stents
1.3.2 Biodegradable Polymer Stents
1.3.3 Resorbable Polymer Stents
1.3.4 Bare Metal Polymer Stents
1.3.5 Drug-Eluting Polymer Stents
1.4 Global Polymer Coronary Stents Market Size by Type
1.4.1 Global Polymer Coronary Stents Market Size Overview by Type (2020-2031)
1.4.2 Global Polymer Coronary Stents Historic Market Size Review by Type (2020-2025)
1.4.3 Global Polymer Coronary Stents Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Polymer Coronary Stents Sales Breakdown by Type (2020-2025)
1.5.2 Europe Polymer Coronary Stents Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Polymer Coronary Stents Sales Breakdown by Type (2020-2025)
1.5.4 South America Polymer Coronary Stents Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Polymer Coronary Stents Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Polymer Coronary Stents Industry Trends
2.2 Polymer Coronary Stents Industry Drivers
2.3 Polymer Coronary Stents Industry Opportunities and Challenges
2.4 Polymer Coronary Stents Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Polymer Coronary Stents Revenue (2020-2025)
3.2 Global Top Players by Polymer Coronary Stents Sales (2020-2025)
3.3 Global Top Players by Polymer Coronary Stents Price (2020-2025)
3.4 Global Polymer Coronary Stents Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Polymer Coronary Stents Major Company Production Sites & Headquarters
3.6 Global Polymer Coronary Stents Company, Product Type & Application
3.7 Global Polymer Coronary Stents Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Polymer Coronary Stents Market CR5 and HHI
3.8.2 Global Top 5 and 10 Polymer Coronary Stents Players Market Share by Revenue in 2024
3.8.3 2023 Polymer Coronary Stents Tier 1, Tier 2, and Tier 3
4 Polymer Coronary Stents Regional Status and Outlook
4.1 Global Polymer Coronary Stents Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Polymer Coronary Stents Historic Market Size by Region
4.2.1 Global Polymer Coronary Stents Sales in Volume by Region (2020-2025)
4.2.2 Global Polymer Coronary Stents Sales in Value by Region (2020-2025)
4.2.3 Global Polymer Coronary Stents Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Polymer Coronary Stents Forecasted Market Size by Region
4.3.1 Global Polymer Coronary Stents Sales in Volume by Region (2026-2031)
4.3.2 Global Polymer Coronary Stents Sales in Value by Region (2026-2031)
4.3.3 Global Polymer Coronary Stents Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Polymer Coronary Stents by Application
5.1 Polymer Coronary Stents Market by Application
5.1.1 Drug-Eluting
5.1.2 Post-Procedure Management
5.1.3 Percutaneous Coronary Intervention (PCI)
5.2 Global Polymer Coronary Stents Market Size by Application
5.2.1 Global Polymer Coronary Stents Market Size Overview by Application (2020-2031)
5.2.2 Global Polymer Coronary Stents Historic Market Size Review by Application (2020-2025)
5.2.3 Global Polymer Coronary Stents Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Polymer Coronary Stents Sales Breakdown by Application (2020-2025)
5.3.2 Europe Polymer Coronary Stents Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Polymer Coronary Stents Sales Breakdown by Application (2020-2025)
5.3.4 South America Polymer Coronary Stents Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Polymer Coronary Stents Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Wego Healthcare
6.1.1 Wego Healthcare Comapny Information
6.1.2 Wego Healthcare Business Overview
6.1.3 Wego Healthcare Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Wego Healthcare Polymer Coronary Stents Product Portfolio
6.1.5 Wego Healthcare Recent Developments
6.2 Shandong Huaan Biotechnology
6.2.1 Shandong Huaan Biotechnology Comapny Information
6.2.2 Shandong Huaan Biotechnology Business Overview
6.2.3 Shandong Huaan Biotechnology Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shandong Huaan Biotechnology Polymer Coronary Stents Product Portfolio
6.2.5 Shandong Huaan Biotechnology Recent Developments
6.3 SINOMED
6.3.1 SINOMED Comapny Information
6.3.2 SINOMED Business Overview
6.3.3 SINOMED Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 SINOMED Polymer Coronary Stents Product Portfolio
6.3.5 SINOMED Recent Developments
6.4 Translumina Therapeutics
6.4.1 Translumina Therapeutics Comapny Information
6.4.2 Translumina Therapeutics Business Overview
6.4.3 Translumina Therapeutics Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Translumina Therapeutics Polymer Coronary Stents Product Portfolio
6.4.5 Translumina Therapeutics Recent Developments
6.5 SLTL Medical
6.5.1 SLTL Medical Comapny Information
6.5.2 SLTL Medical Business Overview
6.5.3 SLTL Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 SLTL Medical Polymer Coronary Stents Product Portfolio
6.5.5 SLTL Medical Recent Developments
6.6 Scitech Medical
6.6.1 Scitech Medical Comapny Information
6.6.2 Scitech Medical Business Overview
6.6.3 Scitech Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Scitech Medical Polymer Coronary Stents Product Portfolio
6.6.5 Scitech Medical Recent Developments
6.7 Rontis
6.7.1 Rontis Comapny Information
6.7.2 Rontis Business Overview
6.7.3 Rontis Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Rontis Polymer Coronary Stents Product Portfolio
6.7.5 Rontis Recent Developments
6.8 REVA Medical
6.8.1 REVA Medical Comapny Information
6.8.2 REVA Medical Business Overview
6.8.3 REVA Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 REVA Medical Polymer Coronary Stents Product Portfolio
6.8.5 REVA Medical Recent Developments
6.9 Purple Microport
6.9.1 Purple Microport Comapny Information
6.9.2 Purple Microport Business Overview
6.9.3 Purple Microport Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Purple Microport Polymer Coronary Stents Product Portfolio
6.9.5 Purple Microport Recent Developments
6.10 Meril Life
6.10.1 Meril Life Comapny Information
6.10.2 Meril Life Business Overview
6.10.3 Meril Life Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Meril Life Polymer Coronary Stents Product Portfolio
6.10.5 Meril Life Recent Developments
6.11 InSitu Technologies
6.11.1 InSitu Technologies Comapny Information
6.11.2 InSitu Technologies Business Overview
6.11.3 InSitu Technologies Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.11.4 InSitu Technologies Polymer Coronary Stents Product Portfolio
6.11.5 InSitu Technologies Recent Developments
6.12 HEALTHCARE TECHNOLOGY
6.12.1 HEALTHCARE TECHNOLOGY Comapny Information
6.12.2 HEALTHCARE TECHNOLOGY Business Overview
6.12.3 HEALTHCARE TECHNOLOGY Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.12.4 HEALTHCARE TECHNOLOGY Polymer Coronary Stents Product Portfolio
6.12.5 HEALTHCARE TECHNOLOGY Recent Developments
6.13 Eucatech
6.13.1 Eucatech Comapny Information
6.13.2 Eucatech Business Overview
6.13.3 Eucatech Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Eucatech Polymer Coronary Stents Product Portfolio
6.13.5 Eucatech Recent Developments
6.14 Elixir Medical
6.14.1 Elixir Medical Comapny Information
6.14.2 Elixir Medical Business Overview
6.14.3 Elixir Medical Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Elixir Medical Polymer Coronary Stents Product Portfolio
6.14.5 Elixir Medical Recent Developments
6.15 CeloNova BioSciences
6.15.1 CeloNova BioSciences Comapny Information
6.15.2 CeloNova BioSciences Business Overview
6.15.3 CeloNova BioSciences Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CeloNova BioSciences Polymer Coronary Stents Product Portfolio
6.15.5 CeloNova BioSciences Recent Developments
6.16 Biotronik
6.16.1 Biotronik Comapny Information
6.16.2 Biotronik Business Overview
6.16.3 Biotronik Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Biotronik Polymer Coronary Stents Product Portfolio
6.16.5 Biotronik Recent Developments
6.17 AMG International
6.17.1 AMG International Comapny Information
6.17.2 AMG International Business Overview
6.17.3 AMG International Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.17.4 AMG International Polymer Coronary Stents Product Portfolio
6.17.5 AMG International Recent Developments
6.18 Amaranth Medical Analytics
6.18.1 Amaranth Medical Analytics Comapny Information
6.18.2 Amaranth Medical Analytics Business Overview
6.18.3 Amaranth Medical Analytics Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Amaranth Medical Analytics Polymer Coronary Stents Product Portfolio
6.18.5 Amaranth Medical Analytics Recent Developments
6.19 Alvimedica
6.19.1 Alvimedica Comapny Information
6.19.2 Alvimedica Business Overview
6.19.3 Alvimedica Polymer Coronary Stents Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Alvimedica Polymer Coronary Stents Product Portfolio
6.19.5 Alvimedica Recent Developments
7 North America by Country
7.1 North America Polymer Coronary Stents Sales by Country
7.1.1 North America Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Polymer Coronary Stents Sales by Country (2020-2025)
7.1.3 North America Polymer Coronary Stents Sales Forecast by Country (2026-2031)
7.2 North America Polymer Coronary Stents Market Size by Country
7.2.1 North America Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Polymer Coronary Stents Market Size by Country (2020-2025)
7.2.3 North America Polymer Coronary Stents Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Polymer Coronary Stents Sales by Country
8.1.1 Europe Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Polymer Coronary Stents Sales by Country (2020-2025)
8.1.3 Europe Polymer Coronary Stents Sales Forecast by Country (2026-2031)
8.2 Europe Polymer Coronary Stents Market Size by Country
8.2.1 Europe Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Polymer Coronary Stents Market Size by Country (2020-2025)
8.2.3 Europe Polymer Coronary Stents Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Polymer Coronary Stents Sales by Country
9.1.1 Asia-Pacific Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Polymer Coronary Stents Sales by Country (2020-2025)
9.1.3 Asia-Pacific Polymer Coronary Stents Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Polymer Coronary Stents Market Size by Country
9.2.1 Asia-Pacific Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Polymer Coronary Stents Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Polymer Coronary Stents Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Polymer Coronary Stents Sales by Country
10.1.1 South America Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Polymer Coronary Stents Sales by Country (2020-2025)
10.1.3 South America Polymer Coronary Stents Sales Forecast by Country (2026-2031)
10.2 South America Polymer Coronary Stents Market Size by Country
10.2.1 South America Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Polymer Coronary Stents Market Size by Country (2020-2025)
10.2.3 South America Polymer Coronary Stents Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Polymer Coronary Stents Sales by Country
11.1.1 Middle East and Africa Polymer Coronary Stents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Polymer Coronary Stents Sales by Country (2020-2025)
11.1.3 Middle East and Africa Polymer Coronary Stents Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Polymer Coronary Stents Market Size by Country
11.2.1 Middle East and Africa Polymer Coronary Stents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Polymer Coronary Stents Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Polymer Coronary Stents Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Polymer Coronary Stents Value Chain Analysis
12.1.1 Polymer Coronary Stents Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Polymer Coronary Stents Production Mode & Process
12.2 Polymer Coronary Stents Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Polymer Coronary Stents Distributors
12.2.3 Polymer Coronary Stents Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings